Neurosense Therapeutics Ltd. (NRSN)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 59
-0.01
-2.4917%
$
20.75M Market Cap
- P/E Ratio
- Div Yield
84,871 Volume
-0.8 Eps
$ 0.6
Previous Close Investors:
Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurosense Therapeutics Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RJ Rebecca Judd Pathstone Holdings, LLC | 16,528 | $12,710 | $11,396.06 | -$1,313.94 | -10.34% |
